Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Rhea-AI Summary
Azenta, Inc. (Nasdaq: AZTA) will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-16, 2023. Interested participants should contact their BTIG representative to attend. Azenta is recognized globally for providing life sciences solutions, facilitating faster market delivery of breakthroughs and therapies. Their comprehensive offerings include cold-chain sample management and genomic services, primarily serving pharmaceutical, biotech, academic, and healthcare institutions worldwide. The company is based in Burlington, MA, with operations spanning North America, Europe, and Asia.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AZTA declined 2.48%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
INVESTOR CONTACTS:
Head of Investor Relations & Corporate Communications
ir@azenta.com
sherry.dinsmore@azenta.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-btig-medtech-digital-health-life-science--diagnostic-tools-conference-301743760.html
SOURCE
